Financial Summary (All financials)
| In millions, except per share items | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 | Sep-30-14 | Sep-30-13 | Sep-30-12 |
| Revenues | 12,838.0 | 12,943.0 | 13,263.0 | 12,488.0 | 13,268.0 | 13,783.0 | 13,794.0 | 13,887.0 |
| Revenue growth | -0.8% | -2.4% | 6.2% | -5.9% | -3.7% | -0.1% | -0.7% | -6.9% |
| Cost of goods sold | 6,838.0 | 6,879.0 | 7,436.0 | 6,684.0 | 6,868.0 | 6,542.0 | 6,799.0 | 6,993.0 |
| Gross profit | 6,000.0 | 6,064.0 | 5,827.0 | 5,804.0 | 6,400.0 | 7,241.0 | 6,995.0 | 6,894.0 |
| Gross margin | 46.7% | 46.9% | 43.9% | 46.5% | 48.2% | 52.5% | 50.7% | 49.6% |
| Selling, general and administrative | 3,146.0 | 3,054.0 | 3,002.0 | 2,851.0 | 2,860.0 | 2,899.0 | 2,829.0 | 2,757.0 |
| EBITA | 2,512.0 | 2,612.0 | 2,729.0 | 2,852.0 | 3,454.0 | 4,234.0 | 4,033.0 | 3,976.0 |
| EBITA margin | 19.6% | 20.2% | 20.6% | 22.8% | 26.0% | 30.7% | 29.2% | 28.6% |
| Amortization of intangibles | 40.0 | 31.0 | 29.0 | 33.0 | 34.0 | 40.0 | 63.0 | 63.0 |
| EBIT | 2,472.0 | 2,581.0 | 2,700.0 | 2,819.0 | 3,420.0 | 4,194.0 | 3,970.0 | 3,913.0 |
| EBIT margin | 19.3% | 19.9% | 20.4% | 22.6% | 25.8% | 30.4% | 28.8% | 28.2% |
| Pre-tax income | 2,007.0 | 1,997.0 | 2,212.0 | 1,990.0 | 2,503.0 | 3,514.0 | 3,519.0 | 3,470.0 |
| Income taxes | 445.0 | 269.0 | 293.0 | 519.0 | 501.0 | 1,050.0 | 1,070.0 | 1,085.0 |
| Tax rate | 22.2% | 13.5% | 13.2% | 26.1% | 20.0% | 29.9% | 30.4% | 31.3% |
| Earnings from continuing ops | 1,522.0 | 1,688.0 | 1,871.0 | 1,436.0 | 1,922.0 | 4,856.0 | 4,856.0 | 4,730.0 |
| Earnings from discontinued ops | 26.0 | 31.0 | 3.0 | 2.0 | | -1.0 | -12.0 | -364.0 |
| Net income | 1,548.0 | 1,719.0 | 1,874.0 | 1,438.0 | 1,922.0 | 4,855.0 | 4,844.0 | 4,366.0 |
| Net margin | 12.1% | 13.3% | 14.1% | 11.5% | 14.5% | 35.2% | 35.1% | 31.4% |
| |
| Diluted EPS | $3.77 | $4.19 | $4.67 | $3.61 | $4.73 | $11.03 | $9.81 | $8.80 |
| Shares outstanding (diluted) | 403.8 | 403.0 | 400.6 | 398.0 | 406.0 | 440.2 | 494.8 | 537.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|